by Acurable • Model: AcuPebble SA100
The AcuPebble SA100 is a miniature, non-invasive wearable device that attaches to the base of the neck to record physiological body sounds. It uses patented acoustic signal processing to automatically extract diagnostic parameters for sleep apnea, such as AHI and ODI, without requiring training or restrictive chest belts.
Eligibility may vary by provider and plan. Check with your HSA/FSA administrator for specific details.
Evidence-based evaluation by medical professionals
"A revolutionary wearable that replaces complex belts and cannulas with a single acoustic sensor for high-accuracy, automated OSA diagnosis."
The AcuPebble SA100, developed by Acurable, introduces a novel approach to home sleep apnea testing by utilizing acoustic sensing technology. Instead of traditional channels like nasal airflow or finger pulse oximetry, the device is a single 7-gram sensor attached to the suprasternal notch of the neck with medical adhesive. It records the physiological sounds generated by respiratory and cardiac functions, which are then processed by patented algorithms to derive key diagnostic parameters including the Apnea-Hypopnea Index (AHI) and Oxygen Desaturation Index (ODI). A landmark study published in BMJ Open demonstrated that the AcuPebble SA100 achieved a 95.33% diagnostic accuracy when compared against gold-standard polygraphy. The system is entirely automated; patients follow instructions via a mobile app, upload their data to the cloud, and a clinically validated report is generated instantly for the healthcare provider.
Ranked #5 of 25 clinically evaluated home sleep tests devices
Withings
Sunrise SA
Acurable
You're viewing this
Acurable
Our #1-ranked home sleep tests device demonstrated superior performance across key clinical metrics. Compare detailed specifications to make an evidence-based selection.
Verified retailers and current pricing
Prescription required; primarily B2B supply to clinics and hospitals.
Price includes diagnostic test, clinical report, and specialist consultation (GBP 370).
